seven patients with invasive infections due to Rhodococcus equi were treated in Taiwan. Four patients had pulmonary lesions, and one each of the remaining three patients had a recurrent Port-A-Cath (Kabi-Pharmacia, North Ryde, New South Wales, Australia) -related bacteremia, a primary bacteremia, and a brain abscess. Three patients had underlying hematologic malignancies, and one each of the remaining four patients had diabetes mellitus, Waldenströ m's macroglobulinemia, long-term use of steroids, and AIDS. The 13 isolates of R. equi recovered from these patients were identified by using API Coryne System (bioMérieux, Marcy l'Etoile, France), VITEK GPI card (bioMérieux Vitek, Hazelwood, MO), supplemental biochemical tests, and cellular fatty acid chromatograms. Susceptibilities of these isolates to 16 antimicrobial agents, with use of the agar dilution method, varied; among them, amikacin and trimethoprim -sulfamethoxazole were the most active agents. Different random amplified polymorphic DNA (RAPD) patterns of isolates from different patients documented the lack of epidemiological relatedness of the causative organisms of these infections. This study confirms the emergence of multidrug-resistant R. equi infection in Taiwan and documents the relapsing or reactivating nature of this infection.
Since the first description of human infection due to Rhodocontaminated soil, or manure [2, 5, 6] . Most infections due to Rhodococcus species are community acquired [1 -13] ; howcoccus equi (formerly Corynebacterium equi) in 1967 [1] , this organism has been increasingly recognized as an opportunistic ever, nosocomial infections or hospital outbreaks have been reported [14, 15] . pathogen of clinical importance among immunocompromised hosts, particularly those infected with HIV [2 -5] . R. equi are From November 1995 to October 1997, we identified seven patients with invasive infections due to R. equi. To understand aerobic, nonmotile, nonspore-forming, pleomorphic, gram-positive and partially acid-fast bacilli (AFB) [6] . They are widely the clinical characteristics and outcome of infections due to R. equi in Taiwan and the probable epidemiological relatedness, distributed among livestock and livestock environments [2, 5, 6] . The incidence of human infection due to R. equi may be we reviewed the medical records of the seven patients and studied the microbiological characteristics of 12 isolates recovunderestimated because the organisms are commonly misidentified as a normal flora or as other contaminants, because of ered from these patients, including antimicrobial susceptibilities, cellular fatty acid profiles, and molecular typing. incomplete or inappropriate identification [2, 5, 6] . Pleuropulmonary infection, commonly presenting as chronic and relapsing cavitary pneumonia, is the most common clinical manifestation of infection due to R. equi [2 -5, 7] . Extrapulmonary
Patients and Methods

R. equi infections most likely represent secondary foci due
Clinical data. Records of all clinical specimens submitted to hematogenous dissemination [8 -11] . Reports of cases of for culture to the microbiology laboratory at National Taiwan extrapulmonary infection without pulmonary involvement are University Hospital from January 1987 to October 1997 that rare [2, 5, 9, 11 -13] . Frequently, infected patients have a hiswere positive for Rhodococcus species were reviewed. During tory of contact with farm animals (especially horses and foals), this period, 13 R. equi isolates were recovered from various specimens obtained from six patients who were treated at the hospital from November 1995 to October 1997. The other one devices, chemotherapy, and bone marrow transplantation), other than Haemophilus species, Neisseria gonorrhoeae, and streptococci [17] . The NCCLS criteria for staphylococci were source and date of isolation, antimicrobial therapy, and outcome.
adopted for defining susceptibilities to penicillin and amoxicillin/clavulanic acid. The presence of b-lactamases among these Bacterial isolates. The isolates were initially identified from colonial and microscopic morphology, properties on Kiisolates was determined with use of a cefinase disk (BBL Microbiology Systems). nyoun staining, and biochemical characteristics determined by using the API Coryne system (bioMérieux, Marcy l'Etoile, Random amplified polymorphic DNA (RAPD) analysis. All isolates were incubated in brain-heart infusion broth (Difco France), API ZYM, and the VITEK GPI card (bioMérieux Vitek, Hazelwood, MO) [6] . These isolates were confirmed as Laboratories, Detroit, MI) for 36 -48 hours at 35ЊC in ambient air. Bacterial genomic DNA was extracted by using a commer-R. equi with use of supplemental tests including the presence of equi factor (CAMP test); catalase, urease, lipase, and oxidase cial kit (Puregene; Gentra Systems, Inc., Minneapolis). The random amplified polymorphic DNA (RAPD) assay, generated reactions; orthonitrophenyl-b-D-galactopyranoside (ONPG); growth on MacConkey, agar; and hydrolysis of xanthine, tyroby arbitrarily primed PCR (APPCR), was performed using the following two arbitrary oligonucleotide primers: H3 (5-AGAsine, hypoxanthine, and gelatin, as described by Prescott [2] .
Cellular fatty acid analysis. For cellular fatty acid analysis, CGTCCAC-3) and H4 (5-GGAAGTCGCC-3) (OPERON Technologies, Inc., Alameda, CA). The conditions for PCR the isolates were incubated in trypticase soy agar (BBL Becton Dickinson Microbiology Systems, Cockeysville, MD). Procefollowed the previous description [16] .
Definitions. Infections that developed §72 hours after dures for preparation and identification of fatty acid methyl esters and the instrument used were the same as the previous admission were regarded as nosocomial, whereas those infections that developed earlier were considered community acdescription [16] . The software library used to identify the Rhodococcus species was TSA, version 3.9 (Microbial ID, Newark, quired. Antimicrobial therapy given within 48 hours of admission was considered appropriate if at least one of the DE). A major peak of the esterified fatty acid was defined as an area percentage §3% of the area of the total esterified agents administered was active against the R. equi isolates in vitro. A response to antibiotic therapy was defined as fatty acid of the isolate; a minor peak was defined as an area percentage õ3% of the total esterified fatty acid of the isolate.
complete resolution of all clinical and microbiological signs and symptoms of infection, except in cases of pneumonia. The similarity index (ranges, 0 -1) was defined as the closeness of a match of the unknown bacterium to a library entry. A Among the patients with pneumonia, response was defined as resolution of all symptoms, sputum and blood cultures similarity index of ú0.6 was defined as an excellent match.
Antimicrobial susceptibility testing. MICs of 16 antimicronegative for R. equi, and significant improvement in condition, demonstrated by chest radiographs. A response to initial bial agents for the 13 isolates of R. equi were determined according to the National Committee for Clinical Laboratory antimicrobial therapy (initial response) was determined at the point when the initial regimen was discontinued. Standards (NCCLS) guidelines [17] . The following antimicrobial agents were obtained from the corresponding manufacturAntibiotypes of the isolates were considered different if the MICs for at least two of the antimicrobial agents tested ers as standard reference powders of known potency for laboratory use: penicillin G, ampicillin/sulbactam, cefuroxime, were at least a two-dilution discrepancy. Both faint and intense bands were included for the interpretation of RAPD trimethoprim-sulfamethoxazole (TMP-SMZ), erythromycin, rifampin, and vancomycin (Sigma Chemical, St. Louis); amoxipatterns [16] . Patterns differing by more than one band were considered different; otherwise, they were considered identicillin/clavulanic acid (Beecham Research Laboratories, Brentford, England); ceftriaxone (Roche Laboratories, Nutley, NJ);
cal. Isolates were defined as the same strain or considered to be derived from a single clone if they had identical antibioaztreonam and amikacin (Bristol-Myers Squibb Laboratories, New York); imipenem (Merck Sharp & Dohme, West Point, types and identical RAPD patterns [16] . A relapse was defined as recurrence of an infection due to the same R. equi PA); minocycline (Lederle Laboratories, Pearl River, NY); clarithromycin (Abbott Laboratories, Abbott Park, IL); ofloxaclone. cin (Daiichi Pharmaceutical, Tokyo, Japan); and ciprofloxacin (Bayer, Leverkusen, Germany).
Results The MICs of the antimicrobial agents that were tested ranged from 0.03 mg/mL to 256 mg/mL. All patients had underlying diseases. Three of them had hematologic malignancies, and one had AIDS. None of the patients were used as control strains. Because the resistant and susceptible MIC breakpoints for Rhodococcus species are not defined had a known history of contact with any animal sources. Two patients (patients 3 and 6) had had more than one admission by the NCCLS, the percentage of isolates susceptible or resistant to antimicrobial agents was classified presumptively by to the same ward within an interval of 3 months for scheduled chemotherapy before the documentation of R. equi infection, application of the susceptibility breakpoints used for organisms / 9C52$$AU35 07-09-98 19:55:48 cida UC: CID NOTE. Amik Å amikacin; AML Å acute myelocytic leukemia; Amp/Sulb Å ampicillin/sulbactam; BMT Å bone marrow transplantation; CA Å community acquired; Cpfx Å ciprofloxacin; Clm Å clarithromycin; COPD Å chronic obstructive pulmonary disease; DM Å diabetes mellitus; Gm Å gentamicin; Imi Å impenem; N Å nosocomial; Ofx Å ofloxacin; Rif Å rifampin; TMP-SMZ Å trimethoprim-sulfamethoxazole; Vm Å vancomycin.
* See figure 1.
and they also had the Port-A-Cath (Kabi-Pharmacia, North phology of R. equi isolates was variable: one type (three isolates) was pink and mucoid, and the other type (ten isolates) Ryde, New South Wales, Australia) implants. Patient 3 had positive cultures of a blood specimen collected via a Port-Awas coral colored and nonmucoid. All isolates were catalase, lipase, and urease positive and oxidase negative. They all proCath and peripheral veins on three occasions. Gram-stained smear of the blood aspirated from the removed Port-A-Cath duced equi factor on interaction with S. aureus. None of the isolates hydrolyzed xanthine, tyrosine, or hypoxanthine, and tip disclosed many gram-positive bacilli that were later identified as R. equi. Patient 4 acquired nosocomial R. equi septiceall were negative for the ONPG reaction. Results of API ZYM gave enzyme profiles that were characteristic for R. equi [2] . mia 1 month after admission, and positive cultures were documented for two sets of blood specimens. Among the four Cellular fatty acid chromatograms. Figure 1 shows the cellular fatty acid chromatogram for R. equi isolates. All isopatients who had pulmonary lesions, one patient (patient 7) had a liver biopsy specimen positive for R. equi but had no lates had major peaks for the following fatty acids: 2-hydroxy-13-methyltetra decanoic acid (i-2-OH-15:0), hexadecanoic acid microbiological documentation of R. equi from the lung lesions. The other three patients (patients 1, 5, and 6) recovered, and (16:0), cis-9-octadecanoic acid (18:1 w9c), and 10-methyloctadecanoic acid methyl ester (10 Me 18:0), and minor peaks for their lung lesions disappeared after antibiotic treatment.
There was recurrence of infection in two patients with initial myristic acid (14:0), pentadecanoic acid (15:0), and octadecanoic acid (18:0). The similarity indices of these isolates with responses: patient 6 developed fulminant pneumonia 2 weeks after treatment, and patient 3 had an additional two episodes the identification of Rhodococcus species ranged from 0.7 to 0.8. of bacteremia within 5 months after treatment. All patients were treated with antimicrobial agents for 2 -4 months, and all Antimicrobial susceptibilities. MICs of the 16 antimicrobial agents for the isolates are shown in table 2. Seven antibiosurvived, except one patient (patient 2) who died 2 days after treatment of acute lung edema unrelated to R. equi infection.
types were identified among the 13 isolates. Isolates from different patients possessed different antibiotypes; otherwise, Bacterial isolates. All isolates were gram-positive and weakly positive for AFB with use of modified Kinyoun stainantibiotypes from isolates recovered from the same patients (isolates C1 -C4 from patient 3 and isolates F1 -F4 from patient ing. The typical cyclic microscopic morphology was found on trypticase soy agar supplemented with 5% sheep blood (BBL 6) were identical. All isolates were susceptible to amikacin and TMP-SMZ. Susceptibilities to the other 14 agents were Becton Dickinson Microbiology Systems). The colonial mor-/ 9C52$$AU35 07-09-98 19:55:48 cida UC: CID mg/mL), and rifampin (MICs, ú256 mg/mL). Isolates E, F1 -F4, and G were b-lactamase positive; the other isolates were b-lactamase negative. RAPD patterns. RAPD patterns for the 13 isolates by the primers H3 and H4 are shown in figure 2. Isolates from different patients had different RAPD patterns. Identical RAPD patterns were found for the four isolates (C1 -C4) from patient 3, and the four isolates (F1 -F4) from patient 6.
Discussion
This retrospective study of the clinical features of the first seven Taiwanese patients with infections due to R. equi and the microbiological characterization of the 13 isolates from these patients disclosed four important points. (1) To our knowledge, we have reported the first presence of R. equi in Taiwan, and this organism should be considered an emerging pathogen in this geographic area. (2) We documented invasive infections in humans due to R. equi strains that are highly resistant to extended-spectrum b-lactams, imipenem, macrolides, and rifampin, for which reports are rare [2 -4] . (3) This is the first application of phenotypic and genotypic methods to confirm the relapsing or reactivating nature of infection due to R. equi among immunocompromised hosts and to rule out nosocomial spread of this organism. (4) We report the first case of Port-A-Cath -related bacteremia due to R. equi, as well and enzymatic characteristics is needed, and such analyses are not feasible in routine clinical microbiology laboratories [2, 5, 6] . Cellular fatty acid analysis by gas-liquid chromatography has been useful for the species-level identification of a large variable. Isolates E, F1 -F4, and G, which were less susceptible (MICs, 32 mg/mL to ú256 mg/mL) to cefotaxime, ceftriaxone, number of bacteria [16] . However, as shown in this study, the application of this analysis for identifying R. equi is limited. imipenem, and aztreonam were also less susceptible to erythromycin (MICs, ú16 mg/mL), clarithromycin (MICs, §16
Previous studies have shown that ribotype analysis could be [2, 5, 20, 21] . The organism is usually less susceptible to penicillin, ampicillin, cephalosporins, or quinolones [2, 4, 5, 20, 21] . Our susceptibility results partly support the previous findings. It is of interest that three of the seven strains from patients with community-acquired infections had inherent concomitant resistance to all b-lactams, aztreonam, macrolides, and rifampin. This finding is unique to isolates from other geographic areas.
For selection of appropriate agents to treat R. equi infections, both the in vivo and in vitro properties of the antimicrobial agents should be considered [21] . One of the patients (patient 6) had a relapse of infection after treatment with vancomycin, which has good in vitro efficacy but a low level of uptake by of resistance to the agents used. It is suggested that combination therapy is more effective than monotherapy, because the former might reduce the mutation frequencies of resistance to antimiuseful for studying the relatedness of R. equi isolates [5, 19] . In addition, RAPD-pattern analysis based on APPCR has a crobial agents [2 -5, 20, 21] . Our study further confirms that an initial treatment regimen consisting of a combination of at high discriminatory power for the molecular typing of these organisms, as demonstrated in the current study.
least two agents with bactericidal action and intracellular activity might be crucial for adequate treatment. Recently, the majority of reported cases of infections due to R. equi have been among patients infected with HIV [3, 4] .
Previous studies have shown that the mortality associated with R. equi infection is higher for HIV-infected patients Most of the patients with R. equi infections who were not HIV infected had a history of significant contact with livestock or than for non-HIV-infected patients [3, 4] . The frequent simultaneous opportunistic infections that occur among HIV-inwith soil that was heavily contaminated with this organism [2, 4 -6] . In contrast, only one of our patients was infected with fected patients and patients with deep-tissue infections treated with antibiotics alone, without surgical intervention, HIV. None of them had a definite history of exposure to livestock or soil that was heavily contaminated with livestock might have contributed to the higher mortality [4] . In the present study, all patients with R. equi infection recovered, waste. Although the soil habits of this organism and the associated zoonoses have been confirmed in different geographic including the patient with AIDS (patient 1) who had no concomitant infection, although one patient (patient 7) had multiareas, no such data existed in Taiwan [5, 6] .
Most infections due to Rhodococcus species are community ple cavitary lung lesions and had not undergone repeated aspiration or surgical drainage. acquired [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Nosocomial infections associated with the use of indwelling devices or due to contaminated closed-system packed In summary, the first seven cases of R. equi infection in Taiwan, which all occurred during a 2-year period, were epideRBCs have been reported [14, 15] . Two of the patients in our / 9C52$$AU35 07-09-98 19:55:48 cida UC: CID
